INK4a
and another CDKI, p21 CIP1/WAF1 , induces senescence without a SASP, even though they induced other features of senescence, including a stable growth arrest. Additionally, human fibroblasts induced to senesce by ionizing radiation or oncogenic RAS developed a SASP regardless of whether they expressed p16 INK4a . Cells induced to senesce by ectopic p16 INK4a Organisms with renewable tissues are at risk for developing hyperproliferative diseases, the most deadly of which is cancer. This risk is mitigated by tumor suppressor mechanisms, which suppress cancer for much of the life span (1) (2) (3) . Some tumor suppressor mechanisms act by preventing damaged or mutant cells from developing into a tumor by eliminating them entirely (apoptosis); others do so by permanently arresting their proliferation (cellular senescence).
Virtually all cancers harbor mutations in the tumor suppressor pathways that mediate the senescence response (4, 5) . Senescent cells are found in premalignant lesions, where they appear to have prevented malignant progression (6, 7) . Interestingly, in culture and in vivo, some tumor cells retain the ability to senesce in response to DNA damaging chemotherapy; in vivo, tumor cell senescence results in arrested tumor growth or eventual tumor regression (8) (9) (10) (11) (12) .
Senescent cells acquire a complex phenotype, the regulation of which is incompletely understood. Senescent phenotypes include an essentially permanent growth arrest, increased cell size, expression of a senescenceassociated beta-galactosidase activity (SA-Bgal) and resistance to apoptosis (13, 14) . Senescent cells also show numerous changes in gene expression, notably the increased expression of many secreted proteins, which we term the senescence-associated secretory phenotype (SASP) (15) .
The SASP includes inflammatory cytokines, growth factors and proteases, and may explain the seemingly paradoxical characteristics of senescence: suppression of cancer by blocking the proliferation of damaged cells, but also stimulation of tissue repair and age-associated pathologies, by altering the tissue microenvironment (15, 16) .
Senescent cells increase with age in many renewable tissues (17) (18) (19) (20) . They are also found at sites of age-related pathologies, including degenerative disorders such as osteoarthritis (21) and atherosclerosis (22) , as well as hyperproliferative lesions such as benign prostatic hyperplasia (23) and melanocytic naevi (24) . Numerous cell culture and mouse xenograft studies support the idea that senescent cells secrete factors that can disrupt tissue structure and function, and promote cancer progression (12, (25) (26) (27) (28) (29) (30) .
The senescence response is controlled by two potent tumor suppressors, p53 and pRB, that lie at the heart of interacting pathways (3, 31) . Among the important components of these pathways are cyclin-dependent kinase inhibitors (CDKI). CDKIs inhibit critical cell cycle-regulatory phosphorylation events, such as those that inactivate the growth suppressive activity of pRB (32) .
One such CDKI, p21 CIP1/WAF1 (CDKN1A), is a direct target of p53 transactivation, generally in response to genomic damage, and is crucial for establishing and maintaining the p53-mediated senescence growth arrest (5, 33) . Another CDKI, p16
(CDKN2A), is a tumor suppressor in its own right, can be induced by stress that does not entail DNA damage (14, 34, 35) , and acts upstream of pRB to establish the pRB-regulated growth arrest (5, 36, 37) .
The senescence response is induced by many potentially oncogenic stimuli, including dysfunctional telomeres, DNA damage and strong mitogenic signals such as those delivered by certain oncogenes. Many of these stimuli, directly or indirectly cause DNA damage and activate the DNA damage response (DDR) (13, 14) . The DDR contributes to senescence in two ways. First, it activates p53, which arrests cell proliferation largely through p21 CIP1/WAF1 (33) . At low levels of damage, the DDR is transient, but high levels cause chronic low-level DDR signaling and p53 activation, which maintain a senescence growth arrest (37, 38) . Second, the DDR activates a subset of the SASP, but independent of p53 activity; loss of p53 function amplifies the SASP, suggesting that p53 restrains this phenotype (12, 38) . The SASP is additionally regulated by microRNAs, the cytokine receptor CXCR2, IL-1 receptor signaling, the transcription factors C/EBPbeta and NF-KB, and the JAK/STAT signaling pathway (38) (39) (40) (41) (42) (43) (44) . It has also been suggested that ectopic expression of p16
INK4a does not trigger IL-6 secretion (38), but virtually nothing is known about whether the p16
INK4a /pRB pathway regulates or influences the SASP or its paracrine effects.
While the DDR/p53-mediated induction of p21 CIP1/WAF1 and onset of growth arrest is rapid, the SASP requires several days to develop after cells receive sufficient damage to cause senescence. Senescence-inducing DNA damage also induces p16 INK4a , with kinetics and under conditions similar to those that result in a SASP (12, 38, 45, 46) .
Further, as a downstream mediator and upstream regulator of the p53 and pRB pathways, respectively, ectopic p21
and p16
INK4a expression can induce a senescence growth arrest, senescent morphology and SABgal expression (47) . It is not known whether these CDKIs induce or modulate a SASP.
Here, we show that the SASP is not an essential characteristic of senescent cells and is independent of p16 INK4a status. We show that senescent human fibroblasts from varying origins display a similar SASP, regardless of whether they express p16 INK4a . However, p16
INK4a activity had an indirect effect on the SASP by limiting the proliferation of damaged cells.
Finally, ectopic p16 INK4a expression induced a senescence growth arrest without a concomitant SASP, indicating that the growth arrest is not sufficient to cause a SASP.
EXPERIMENTAL PROCEDURES
Cells. Human cells were obtained as described (12) , and cultured in 3% oxygen for at least 4 doublings prior to use; primary mouse cells were established and cultured in 3% oxygen. All cultures were considered presenescent (PRE) if, when subconfluent in 10% serum, >70% of cells incorporated BrdU over a 1 d interval and <5% stained for SA-Bgal; cultures were considered senescent (SEN) if <10% of cells incorporated BrdU over a 1 d interval and >80% were SABgal positive. All SEN cells used here were senescent by these criteria. Cells were induced to senesce by ionizing radiation (10 Gy X-ray) or expression of oncogenic RAS V12 , p16 INK4a or p21 CIP1/WAF1 , and were senescent by the above criteria 10-12 d later. Alternatively, cells were repeatedly subcultured until proliferation ceased (replicative senescence). Presenescent cultures were made quiescent by culturing to confluence (1 d BrdU labeling index declined from >70% to <10%). To express p16
INK4a , p21 CIP1/WAF1 or Ras V12 , cells were infected with lentiviruses carrying no insert (control) or the indicated cDNAs, as described (12, 38, 48, 49 ) (sFig. 1A). Antibody arrays. Conditioned media (CM) were collected from control or senescent cells 10 d following irradiation or 12 d following infection with lentiviruses and analyzed using Human Cytokine Antibody Arrays (C series 1000; Chemicon); volumes equivalent to 1.5x10 6 cells were diluted to 1.2 ml with DMEM, and used to probe the array membranes, as described (12, 29) . Array data are newly generated but display SASP factors previously shown as most upregulated by SEN cells (12) . Statistical analysis and data clustering. Antibody array and TaqMan data were analyzed using publicly available software (http://rana.lbl.gov/EisenSoftware.htm) (12, 50) . Color-coding is as follows: baseline value is black, above baseline is yellow and below baseline is blue. Colors were chosen so that the highest variations reached yellow or blue saturation (see color scale, Figs. 1C, 2A). For TaqMan data above and below baseline colors were red and green, respectively (Fig. 1B, 2E ). Error bars correspond to the standard deviation around the mean. We calculated significance using a Student t-test. ELISA, immunofluorescence and mRNA measurements. ELISAs were performed as described (12, 38) using commercially available kits (R&D Systems). Immunofluorescence was performed as described (38) using antibodies from R&D to detect IL-6 (AF-206-NA) and IL-8 (MAB208), BD Biosciences to detect p16 INK4a (JC8), and Bethyl to detect 53BP1 (BL182). TaqMan assays were performed as previously described (12, 29) .
Western blotting.
Western analysis was performed as described (12) INK4a (37, 38) .
RESULTS

CDKIs trigger a senescence growth arrest but not a SASP
To determine whether the SASP is an invariant feature of senescent cells, we compared presenescent (PRE) normal human fibroblasts with cells induced to senesce by replicative exhaustion (SEN(REP)), high dose (10 Gy) X-irradiation (SEN(XRA)) or ectopic p16
INK4a expression (SEN(p16)). We also induced senescence by expressing oncogenic RAS (Ha-RAS V12 ) (SEN(RAS)), which generates an amplified SASP (12) . As reported, all these stimuli caused senescence in all the cultures used in this study, as judged by a stable growth arrest, SA-Bgal expression and a senescent morphology (sFig. 1A) (12, 17, 38, 45, (47) (48) (49) . SEN(REP) and SEN(XRA) cells express SASPs that are qualitatively and quantitatively similar (12) . We confirmed this similarity in multiple strains of primary human fibroblasts by immunostaining for the major SASP proteins IL-6 and IL-8 (sFig. 1A), quantifying secreted levels of IL-6, IL-8 and GROa (another SASP factor) by ELISA ( Fig. 1A; sFig. 1B), and quantifying several SASP factor mRNA levels by qPCR (Fig. 1B; sFig. 1C) . These measurements also confirmed that SEN(RAS) cells express a more robust SASP than SEN(REP) or SEN(XRA) cells (Fig. 1A ; sFig. 1A, B) (12) .
By contrast, ectopic p16 INK4a expression (SEN(P16)) barely changed the secretory profile from that of PRE cells, despite inducing other hallmarks of senescence and high levels of p16
INK4a mRNA (Fig. 1B, sFig. 1C ) and protein (sFig. 1A). This failure to express a SASP was evident by immunostaining (sFig. 1A), ELISA (Fig. 1A, sFig. 1B) and qPCR (Fig. 1B; sFig.  1C) .
It was also evident by analyzing conditioned medium (CM) on antibody arrays designed to detect 120 secreted proteins (12) (Fig. 1C) . Overall, the correlation between the SASPs of SEN(p16) and the other SEN cells was low (<0.3; Fig. 1D ). Further, unsupervised hierarchical clustering showed that the SEN(p16) secretory profile clustered away from other SEN profiles (Fig. 1E) .
Thus, the SEN(p16) profile was no more similar to other SEN profiles than it was to the PRE profile. Finally, SEN(p16) cells did not express a SASP up to 15 days after p16
INK4a expression, indicating that p16
INK4a does not merely delay the kinetics of SASP development.
Every SASP inducer we studied activates p53 (12, 38) and subsequently the CDKI p21 CIP1/WAF1 . We therefore also examined the effect of p21 CIP1/WAF1 on the SASP. Because p53 suppresses the SASP (Coppé et al. 2008) , we did not expect p21 CIP1/WAF1 to induce a SASP, which was indeed the case. As with SEN(p16) cells, fibroblasts induced to senescence by ectopic p21 CIP1/WAF1 (SEN(p21)) expression arrested growth, expressed SA-Bgal and enlarged (47) .
Despite displaying these phenotypes, and expressing high levels of p21 (verified by qPCR, Fig. 1B, sFig. 1C) , SEN(p21) cells did not develop a SASP (Fig. 1A, B ; sFig. 1B, C).
Together, these data demonstrate that high levels of p16 INK4a (and p21 CIP1/WAF1 ), despite inducing several hallmarks of senescence (growth arrest, morphological change and SABgal), do not induce a SASP.
Establishment and maintenance of the SASP are p16
INK4a -independent Some human cell strains (e.g., WI-38, IMR-90) senesce in response to replicative exhaustion, X-irradiation or oncogenic RAS with low level chronic p53 activation and elevated expression of both p21 CIP1/WAF1 and p16 INK4a . Other strains (e.g., BJ, HCA2) express very little p16
INK4a and senesce mainly through the p53/p21 CIP1/WAF1 pathway (37) . To test whether p16
INK4a has any effect on the SASP of cells such as WI-38, we depleted these cells of p16
INK4a using a short hairpin RNA (shp16) (37) (Fig. 1B, 2E and sFig. 1A) and cultured them to replicative senescence (SEN(shp16>REP) ). SEN(shp16>REP) and control (SEN(L3P>REP) (L3P = insertless vector) expressed SASPs that were qualitatively and quantitatively similar, as determined by antibody arrays (Fig. 2A, left  panel) . Among 41 SASP factors identified by the arrays as SEN-associated, the correlation between SEN(shp16>REP) and (SEN(L3P>REP) was >0.7 ( Fig. 2A, right  panel) .
Unsupervised hierarchical clustering showed that, when normalized to profiles of PRE cells, SEN(XRA), SEN(L3P>REP) and SEN(shp16>REP) cells developed secretory profiles that were similar (Fig. 2B) . Thus, the SASPs were independent of p16 INK4a status. As expected, SEN(RAS) cells developed an amplified SASP that clustered away from the other SEN groups, showing that p16
INK4a -depleted cells do not develop an amplified SASP at senescence. This conclusion was supported by ELISA (Fig. 2C) and immunostaining (Fig.  2D , sFig. 1A) assays for IL-6 and IL-8, and qPCR (Fig. 2E, sFig. 1C) .
Immunostaining also showed that individual senescent cells (XRA, REP or RAS) could be simultaneously positive for p16
INK4a and IL-6 (i.e., the expression of both proteins is not mutually exclusive), suggesting that p16 expression after genotoxic stress does not affect the SASP (Fig. 3A) . Indeed, ectopic expression of p16
INK4a in SEN(XRA) HCA2 fibroblasts, which express very low levels of p16 INK4a (37), did not alter the secretory profile. Thus, p16
INK4a did not affect the SASP at either the population or single-cell level.
When cells are synchronously induced to senesce by XRA, p16
INK4a increases slowly over several days, in contrast to the relative rapid (within hours) increase in p21 CIP1/WAF1 (45, 46) . Importantly, unlike the DNA damage/p53-mediated growth arrest, which can be reversed by subsequent p53 inactivation, the p16
INK4a -associated arrest cannot be reversed by subsequent p53, p16
INK4a or pRB inactivation, presumably owing to permanent changes in the chromatin of cell cycle-regulated genes (37, 51) . We therefore asked whether cells induced to senesce by ectopic p16
INK4a expression can develop a SASP upon subsequent genotoxic damage.
We either expressed (p16) or depleted (shp16) p16
INK4a in WI-38 cells. Four days later, we subjected the cells to ionizing radiation (XRA) or expressed oncogenic RAS. ELISA measurements of IL-6 secretion showed that cells developed a SASP whether they expressed high or low p16
INK4a at the time they experienced the senescence-inducing stimulus (Fig. 3B) . Similar results were obtained for IL-8 using SEN(shp16) cells (sFig. 1D). We conclude that the genotoxic-or oncogene-induced SASP is unaffected by p16
INK4a . p16
INK4a indirectly modulates the SASP by modulating DNA damage foci Although p16 INK4a had no effect on the SASP of growth arrested senescent cells (Fig. 2-3) , we previously showed that proliferating human fibroblasts increase inflammatory cytokine expression prior to the terminal cell division of replicative senescence. This increase was limited by p53, correlated with the presence of DNA damage foci, and required functional DDR signaling (38, 44) . These findings suggest that, although p16
INK4a per se does not affect the SASP at senescence, as cells approach replicative senescence, it might similarly dampen cytokine secretion indirectly by limiting proliferation and proliferation-driven DNA damage. Consistent with this idea, WI-38 cells at late passages (40-45 population doublings (PDs)) -but before reaching complete senescence (~50 PDs) -secreted IL-6 at significantly higher levels than early passage (<30 PD) cells (Fig. 4A) .
Further, when depleted of p16 INK4a , late passage cells secreted more IL-6 than unmodified counterparts (similar PDs) (late PRE vs late PRE shp16). Indeed, late passage shp16 cells secreted IL-6 at levels similar to those secreted by fully senescent unmodified cells (SEN(REP)) (Fig. 4A) .
To determine whether the difference in IL-6 secretion between late passage cells with high or low p16
INK4a expression was due to differences in accumulated DNA damage, we immunostained the cells for 53BP1 foci, a marker of DNA double-strand breaks and active DDR signaling (38, 44) . The number of cells with >3 53BP foci increased nearly 2-fold when late passage cells were depleted of p16 INK4a (Fig.  4B-C) .
Thus, because during replicative senescence cells with high p16
INK4a and high DDR signaling are mutually exclusive (52) , and the SASP requires DDR signaling emanating from DDR foci (44), p16INK4a can indirectly suppress the SASP by limiting proliferation and DNA damage accumulation. p16
INK4a -induced senescent cells lack paracrine activities of the SASP
The SASP has potent paracrine activities, including abilities to induce an epithelial-to-mesenchymal transition in nonaggressive human breast cancer cells and stimulate the growth of premalignant epithelial cells (12, 29) . Consistent with the failure of p16
INK4a -induced senescent cells to express a SASP, CM from these cells behaved similarly to PRE CM: when added to non-aggressive human breast cancer cells (ZR75.1), neither altered the ability of the cells form tight colonies (clumps), in contrast to the greater cell scattering, resulting in smaller clump size, induced by SEN(XRA) CM (Fig. 5A, B) . This SASP-induced scattering at least partially depended on secreted IL-6 and IL-8 (Fig. 5B) , which are not secreted by SEN(p16) cells.
In addition, CM from SEN(XRA), but not PRE or SEN(p16), cells stimulated the growth of SCp2 cells (Fig. 5C) , an immortalized mouse mammary epithelial cell line (53) . Likewise, CM from mouse embryo fibroblasts (MEFs) induced to senesce by ectopic p16
INK4a expression did not stimulate SCp2 cell growth, whereas CM from MEFs induced to senesce by X-rays stimulated SCp2 cell growth 3-fold, similar to the effects of 10% serum (Fig. 5D) . Together, the data show that ectopic p16
INK4a expression not only fails to induce a SASP, but also fails to confer paracrine activities typical of cells with a SASP.
DISCUSSION
CDKIs INK4a does not reverse the senescence growth arrest (37), nor provoke an amplified SASP (12) . In this context, the continued proliferation of damaged cells, but not p53 inactivation per se, drives amplification of the SASP (12, 38) . In the case of reversing (12) or bypassing replicative senescence (38) , p53 inactivation drives proliferation in the presence of dysfunctional telomeres and causes a gradual accumulation of DNA damage and development of a SASP, which eventually reaches an amplitude that exceeds the SASP of senescent cells with wild-type p53 (12, 38) . p16
INK4a can also indirectly prevent early emergence of a SASP prior to complete replicative senescence by preventing proliferation and DNA damage accumulation. Likewise, the ability of p53 to restrain the SASP is likely tied to its ability to suppress proliferation, which depends largely on p21 CIP1/WAF1 (33). In these contexts, then, the CDKIs can indirectly prevent modification of the tissue microenvironment caused by senescent cells.
It has been suggested that the SASP is an example of evolutionary antagonistic pleiotropy --a process that has positive effects in young organisms, but unselected negative effects in older individuals (1, 16) . This view is supported by recent reports demonstrating that the SASP can have positive effects, including reinforcement of the senescence growth arrest (40, 41) , prevention of fibrosis during tissue repair (54, 55) , and signaling clearance of senescent cells by the immune system (10, 11 INK4a , they may lack a SASP and therefore fail to stimulate clearance by the immune system. However, p16
INK4a levels also rise after DNA damage. Thus, the origin of cells that express p16
INK4a , which increase with age in mouse and human tissues (56-59), is not yet known.
Our results show that undamaged p16
INK4a -induced senescent cells do not secrete factors that alter the microenvironment, at least in culture assays. We cannot rule out the possibility that CDKIs regulate other secreted factors (not interrogated by the antibody arrays). However, CM from cells induced to senesce by ectopic p16
INK4a expression did not promote phenotypes associated with cancer progression. Thus, some p16
INK4a -positive senescent cells that accumulate in tissues could be neutral with respect to the tissue microenvironment, but could contribute to the age-related loss of regenerative capacity (60) (61) (62) .
Our results indicate that the SASP is not an inevitable consequence of a senescence growth arrest, nor is it tied to the senescence characteristics of cell enlargement and SA-Bgal expression. They also support the idea that the SASP is a consequence of severe DNA damage (38, 44) , and not permanent cell cycle arrest per se. Further, they suggest that stresses that increase p16
INK4a (or p21 CIP1/WAF1 ) expression without DNA damage may induce the beneficial effects of senescence -the arrested growth of stressed cells -without its potentially deleterious effects (disruption of the tissue microenvironment due to the SASP). 
D. Immunofluorescence detection of p16
